NasdaqCM - Nasdaq Real Time Price • USD
Organovo Holdings, Inc. (ONVO)
As of 2:08 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.42 | -0.38 | -1.74 | -1.37 |
Low Estimate | -0.42 | -0.38 | -1.74 | -1.37 |
High Estimate | -0.42 | -0.38 | -1.74 | -1.37 |
Year Ago EPS | -- | -- | -1.98 | -1.74 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 75M | 100M | 75M | 444M |
Low Estimate | 75M | 100M | 75M | 444M |
High Estimate | 75M | 100M | 75M | 444M |
Year Ago Sales | -- | -- | -- | 75M |
Sales Growth (year/est) | -- | -- | -- | 492.00% |
Earnings History
CURRENCY IN USD | 9/30/2023 | 12/31/2023 | ||
---|---|---|---|---|
EPS Est. | -- | -- | -0.43 | -0.44 |
EPS Actual | -- | -- | -0.46 | -0.4 |
Difference | -- | -- | -0.03 | 0.04 |
Surprise % | -- | -- | -7.00% | 9.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.42 | -0.38 | -1.74 | -1.37 |
7 Days Ago | -0.42 | -0.38 | -1.74 | -1.37 |
30 Days Ago | -0.42 | -0.38 | -1.74 | -1.41 |
60 Days Ago | -0.42 | -0.38 | -1.74 | -1.41 |
90 Days Ago | -0.49 | -0.45 | -1.91 | -1.85 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ONVO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 1.30% |
Next Qtr. | -- | -- | -- | 10.60% |
Current Year | 12.10% | -- | -- | 5.10% |
Next Year | 21.30% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.21% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | HC Wainwright & Co.: Buy to Neutral | 8/8/2019 |
Initiated | HC Wainwright & Co.: Buy | 12/13/2018 |
Downgrade | Raymond James: Outperform to Market Perform | 11/10/2017 |
Initiated | Raymond James: Outperform | 1/25/2017 |
Initiated | BTIG: Buy | 12/15/2016 |
Initiated | Evercore ISI Group: Buy | 11/28/2016 |
Related Tickers
SNGX Soligenix, Inc.
0.4001
-1.40%
LGVN Longeveron Inc.
1.8300
-2.14%
NKGN NKGen Biotech, Inc.
1.8400
+25.17%
BRTX BioRestorative Therapies, Inc.
1.4000
+2.19%
PXMD PaxMedica, Inc.
0.7303
-2.92%
PALI Palisade Bio, Inc.
6.33
+28.51%
MLEC Moolec Science SA
1.7510
-29.12%
ADIL Adial Pharmaceuticals, Inc.
1.7486
-7.97%
ALLR Allarity Therapeutics, Inc.
1.4809
+4.29%
BPTH Bio-Path Holdings, Inc.
2.7400
-6.16%